Cardiovascular Magnetic Resonance Late Gadolinium Enhancement Risk Score for Mortality in Patients with Hypertrophic Cardiomyopathy: the HCM-LGE Risk Score

Key Points

• Mortality appears correlated with the gadolinium enhancement risk score in hypertrophic cardiomyopathy patients, indicating clinical significance.
• The study identifies specific metrics that enhance understanding of mortality risks, with implications for patient care.
• Assessment using cardiovascular magnetic resonance data offers insights into hypertrophic cardiomyopathy risk profiles for better prognosis.
• Further validation needed as findings are based on observational analysis; additional research can clarify broader applicability.

Abstract